Her work revolves around the clinical care of breast cancer patients, as well as teaching medical students and house staff. She completed her hematology/oncology fellowship at Penn, during which time she focused on breast cancer clinical therapeutic trials, including development of a clinical trial using Avastin (chemical name: bevacizumab) and Abraxane (chemical name: albumin-bound paclitaxel) to treat metastatic breast cancer patients. She received her medical degree from Washington University in St. Louis, followed by an internal medicine residency at the University of Pennsylvania.